Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases

Valutazione media 4,5
( su 2 valutazioni fornite da Goodreads )
 
9780691121130: Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases

Millions of people in the third world die from diseases that are rare in the first world--diseases like malaria, tuberculosis, and schistosomiasis. AIDS, which is now usually treated in rich countries, still ravages the world's poor. Vaccines offer the best hope for controlling these diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices.


In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: "Pull" programs to stimulate research. Here's how such programs would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost to the afflicted countries.



Strong Medicine details just how these legally binding commitments would work. Ultimately, if no vaccines were developed, such a commitment would cost nothing. But if vaccines were developed, the program would save millions of lives and would be among the world's most cost-effective health interventions.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

From the Back Cover:

"The public health of the developing world is the single issue of greatest significance for humanity over the next half century. This important book offers thoughtful analysis and practical ideas for confronting and addressing this issue through research and development of lifesaving vaccines."--Lawrence H. Summers, President, Harvard University

"Michael Kremer and Rachel Glennerster have produced a work of outstanding importance to the well-being of developing countries. "There are five billion people in the poor world, many suffering from debilitating or fatal diseases. The potential gains in overcoming this human suffering from the development of effective and cost-efficient vaccines are enormous. Yet the economic purchasing power of the rich world favors the development of vaccines and drugs for the rich world. Strong Medicine presents workable incentives for research and development to respond more powerfully to the human needs of poor people. Kremer and Glennerster have produced results that deserve the attention of all those who work in development and that chart a way forward for one of the greatest issues of our time."--Nicholas Stern, Second Permanent Secretary at HM Treasury in the United Kingdom, Visiting Professor at the London School of Economics, and former Chief Economist of the World Bank

"Strong Medicine is full of insights that can make a real difference to the morbid world in which we live. It combines powerful analytical reasoning with practical insights and empirical knowledge to explore a highly promising way of expanding incentives for medicinal research. The possibility of making a significant difference through a commitment to purchase effective vaccines as and when they are developed is thoroughly scrutinized in this definitive investigation, for which we have reason to be grateful."--Amartya Sen, Harvard University, Nobel Laureate in Economic Sciences

"This important book, on how to design markets for drugs to treat millions of diseased people in the developing world, has the added advantage of being an interesting read. The authors convey very well the intellectual excitement associated today with putting mechanism design into practice. They take the reader, one step at a time, through the various levels at which problems might arise and then show how the design is meant to take care of these problems."--Abhijit Banerjee, Massachusetts Institute of Technology

"Michael Kremer is likely the most thoughtful advocate of an exciting new approach for tackling the scourges of AIDS, malaria, and other diseases that primarily afflict the populations of less developed countries. In this book, he and Rachel Glennerster offer by far the most complete discussion I have seen of why this approach--one that would see authorities stimulate private efforts to develop medical treatment by providing a guaranteed market for them--should be adopted, and of how to deal with problems of implementation and design."--Kenneth Sokoloff, University of California, Los Angeles

About the Author:

Michael Kremer is Gates Professor of Developing Societies at Harvard University, Senior Fellow at the Brookings Institution, and NonResident Fellow at the Center for Global Development. He founded and was the first executive director of WorldTeach, a nonprofit organization that places two hundred volunteer teachers annually in developing countries (1986-1989). He previously served as a teacher in Kenya. Rachel Glennerster is Director of the Poverty Action Lab at the Massachusetts Institute of Technology, a center devoted to evaluating the effectiveness of anti-poverty programs. She has worked on health and development policy at the UK Treasury, the Harvard Institute of International Development, and the International Monetary Fund.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

I migliori risultati di ricerca su AbeBooks

1.

Michael Kremer; Rachel Glennerster
Editore: Princeton University Press (2004)
ISBN 10: 0691121133 ISBN 13: 9780691121130
Nuovi Rilegato Quantità: 1
Da
Irish Booksellers
(Rumford, ME, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Princeton University Press, 2004. Hardcover. Condizione libro: New. book. Codice libro della libreria 0691121133

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 15,81
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

2.

Kremer, Michael; Glennerster, Rachel
Editore: Princeton University Press 2004-09-27 (2004)
ISBN 10: 0691121133 ISBN 13: 9780691121130
Nuovi Rilegato Quantità: 1
Da
Good Buy 2 You LLC
(Fredericksburg, VA, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Princeton University Press 2004-09-27, 2004. Hardcover. Condizione libro: New. Brand new, unread copy. Codice libro della libreria M9-2H84-LZIO

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 15,40
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,38
In U.S.A.
Destinazione, tempi e costi

3.

Michael Kremer; Rachel Glennerster
ISBN 10: 0691121133 ISBN 13: 9780691121130
Nuovi Rilegato Quantità: 1
Da
AMAZINGBOOKDEALS
(IRVING, TX, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Hardcover. Condizione libro: BRAND NEW. BRAND NEW. Fast Shipping. Prompt Customer Service. Satisfaction guaranteed. Codice libro della libreria 0691121133BNA

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 25,25
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,41
In U.S.A.
Destinazione, tempi e costi

4.

Michael Kremer, Rachel Glennerster
Editore: Princeton University Press (2004)
ISBN 10: 0691121133 ISBN 13: 9780691121130
Nuovi Rilegato Quantità: 1
Da
Ergodebooks
(RICHMOND, TX, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Princeton University Press, 2004. Hardcover. Condizione libro: New. Codice libro della libreria DADAX0691121133

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 27,50
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,41
In U.S.A.
Destinazione, tempi e costi

5.

Michael Kremer, Rachel Glennerster
Editore: Princeton University Press, United States (2004)
ISBN 10: 0691121133 ISBN 13: 9780691121130
Nuovi Rilegato Quantità: 1
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Princeton University Press, United States, 2004. Hardback. Condizione libro: New. New.. Language: English . Brand New Book. Millions of people in the third world die from diseases that are rare in the first world--diseases like malaria, tuberculosis, and schistosomiasis. AIDS, which is now usually treated in rich countries, still ravages the world s poor. Vaccines offer the best hope for controlling these diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices. In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: Pull programs to stimulate research. Here s how such programs would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost to the afflicted countries.Strong Medicine details just how these legally binding commitments would work. Ultimately, if no vaccines were developed, such a commitment would cost nothing. But if vaccines were developed, the program would save millions of lives and would be among the world s most cost-effective health interventions. Codice libro della libreria AAH9780691121130

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 38,28
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

6.

Michael Kremer, Rachel Glennerster
Editore: Princeton University Press, United States (2004)
ISBN 10: 0691121133 ISBN 13: 9780691121130
Nuovi Rilegato Quantità: 1
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Princeton University Press, United States, 2004. Hardback. Condizione libro: New. New.. Language: English . Brand New Book. Millions of people in the third world die from diseases that are rare in the first world--diseases like malaria, tuberculosis, and schistosomiasis. AIDS, which is now usually treated in rich countries, still ravages the world s poor. Vaccines offer the best hope for controlling these diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices. In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: Pull programs to stimulate research. Here s how such programs would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost to the afflicted countries. Strong Medicine details just how these legally binding commitments would work. Ultimately, if no vaccines were developed, such a commitment would cost nothing. But if vaccines were developed, the program would save millions of lives and would be among the world s most cost-effective health interventions. Codice libro della libreria AAH9780691121130

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 38,45
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

7.

Michael Kremer
Editore: Princeton University Press (2004)
ISBN 10: 0691121133 ISBN 13: 9780691121130
Nuovi Quantità: 1
Da
Books2Anywhere
(Fairford, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Princeton University Press, 2004. HRD. Condizione libro: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Codice libro della libreria WP-9780691121130

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 31,32
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 10,08
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

8.

Michael Kremer
Editore: Princeton University Press (2004)
ISBN 10: 0691121133 ISBN 13: 9780691121130
Nuovi Quantità: > 20
Print on Demand
Da
Pbshop
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Princeton University Press, 2004. HRD. Condizione libro: New. New Book.Shipped from US within 10 to 14 business days.THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice libro della libreria IP-9780691121130

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 41,70
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,41
In U.S.A.
Destinazione, tempi e costi

9.

Michael Kremer, Rachel Glennerster
Editore: Princeton University Press
ISBN 10: 0691121133 ISBN 13: 9780691121130
Nuovi Rilegato Quantità: 1
Da
THE SAINT BOOKSTORE
(Southport, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Princeton University Press. Hardback. Condizione libro: new. BRAND NEW, Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases, Michael Kremer, Rachel Glennerster, Millions of people in the third world die from diseases that are rare in the first world--diseases like malaria, tuberculosis, and schistosomiasis. AIDS, which is now usually treated in rich countries, still ravages the world's poor. Vaccines offer the best hope for controlling these diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices. In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: "Pull" programs to stimulate research. Here's how such programs would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost to the afflicted countries. Strong Medicine details just how these legally binding commitments would work. Ultimately, if no vaccines were developed, such a commitment would cost nothing. But if vaccines were developed, the program would save millions of lives and would be among the world's most cost-effective health interventions. Codice libro della libreria B9780691121130

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 38,34
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 7,78
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

10.

Michael Kremer, Rachel Glennerster
Editore: Princeton University Press, United States (2004)
ISBN 10: 0691121133 ISBN 13: 9780691121130
Nuovi Rilegato Quantità: 10
Da
Book Depository hard to find
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Princeton University Press, United States, 2004. Hardback. Condizione libro: New. New.. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. Millions of people in the third world die from diseases that are rare in the first world--diseases like malaria, tuberculosis, and schistosomiasis. AIDS, which is now usually treated in rich countries, still ravages the world s poor. Vaccines offer the best hope for controlling these diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices. In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: Pull programs to stimulate research. Here s how such programs would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost to the afflicted countries. Strong Medicine details just how these legally binding commitments would work. Ultimately, if no vaccines were developed, such a commitment would cost nothing. But if vaccines were developed, the program would save millions of lives and would be among the world s most cost-effective health interventions. Codice libro della libreria BTE9780691121130

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 51,25
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Vedi altre copie di questo libro

Vedi tutti i risultati per questo libro